Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004474
Status:
COMPLETED
Last Update Posted:
2018-03-12
First Post:
1999-10-18
Brief Title:
Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia
Sponsor:
Roswell Park Cancer Institute
Organization:
Office of Rare Diseases ORD
Organization Data
Organization:
Office of Rare Diseases ORD
Class:
NIH
Study ID:
19914004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Roswell Park Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Richard Champlin
Old Organization:
University of Texas - MD Anderson Cancer Center